FDA Inspection 1062017 — Department of Defense - Army

Department of Defense - Army — FEI 1629552

The FDA completed an inspection of Department of Defense - Army on July 27, 2018 in Fort Cavazos, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
July 27, 2018
Fiscal Year
2018
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Fort Cavazos, TX (United States)